Petra Cetkovska
Pilsen, PL, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Discontinuation and Re-Initiation of Biologic Therapy in Psoriasis: Lessons From Real-World Practice.
Journal: International journal of dermatology
Published: August 13, 2026
Efficacy and drug survival after transitioning to IL-17 inhibitors in patients with psoriasis who did not respond to IL-23 inhibitors: analysis from the BIOREP registry.
Journal: The Journal of dermatological treatment
Published: July 10, 2026
Effective treatment of alopecia areata and psoriasis with baricitinib.
Journal: The British journal of dermatology
Published: March 11, 2026
A randomized, double-blind, phase 3 study to compare efficacy, safety, and immunogenicity between DMB-3115 and reference product ustekinumab in patients with moderate-to-severe chronic plaque psoriasis.
Journal: JAAD international
Published: September 13, 2025
Super-Response to Guselkumab Treatment in Patients With Moderate-to-Severe Psoriasis: Real-World Data With Up to Five Years of Follow-Up in The Czech Republic.
Journal: International journal of dermatology
Published: May 21, 2025
Efficacy and safety of lebrikizumab in atopic dermatitis over 24 weeks: An analysis from the BIOREP registry.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 12, 2025
Real-World Data on Brodalumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: An Observational Study from the Czech Republic BIOREP Registry.
Journal: Advances in therapy
Published: May 22, 2024
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic.
Journal: Dermatology and therapy
Published: September 27, 2023
Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
Journal: Journal of the American Academy of Dermatology
Published: June 16, 2023
Apremilast Use in Severe Psoriasis: Real-World Data from Central and Eastern Europe.
Journal: Advances in therapy
Published: January 18, 2023
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry.
Journal: The Journal of dermatological treatment
Published: May 31, 2022
Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP).
Journal: Dermatologic therapy
Published: May 16, 2022
Last Updated: 09/26/2026